| Literature DB >> 24067382 |
Andrew L Croxford1, Susanne Karbach2, Florian C Kurschus3, Simone Wörtge3, Alexei Nikolaev3, Nir Yogev3, Sabrina Klebow3, Rebecca Schüler3, Sonja Reissig3, Carolin Piotrowski4, Elke Brylla4, Ingo Bechmann4, Jürgen Scheller5, Stefan Rose-John6, F Thomas Wunderlich7, Thomas Münzel8, Esther von Stebut5, Ari Waisman9.
Abstract
The lack of a generally accepted animal model for human psoriasis has hindered progress with respect to understanding the pathogenesis of the disease. Here we present a model in which transgenic IL-17A expression is targeted to the skin in mice, achievable after crossing our IL-17A(ind) allele to the K14-Cre strain. K14-IL-17A(ind/+) mice invariably develop an overt skin inflammation bearing many hallmark characteristics of human psoriasis including dermal infiltration of effector T cells, formation of neutrophil microabscesses, and hyperkeratosis. IL-17A expression in the skin results in upregulated granulopoiesis and migration of IL-6R-expressing neutrophils into the skin. Neutralization of IL-6 signaling efficiently reduces the observed pathogenesis in skin of IL-17A-overexpressing mice, with marked reductions in epidermal neutrophil abscess formation and epidermal thickening. Thus, IL-6 functions downstream of IL-17A to exacerbate neutrophil microabscess development in psoriasiform lesions.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24067382 DOI: 10.1038/jid.2013.404
Source DB: PubMed Journal: J Invest Dermatol ISSN: 0022-202X Impact factor: 8.551